Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
03/12/2009 | WO2009032326A1 New tetracycline derivatives as antiinfective agents |
03/12/2009 | WO2009032277A1 Gamma secretase modulators |
03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
03/12/2009 | WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
03/12/2009 | WO2009030819A1 Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof |
03/12/2009 | WO2009029998A1 Retrometabolic compounds |
03/12/2009 | WO2009018106A3 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
03/12/2009 | WO2009010846A3 Amorphous form of darifenacin hydrobromide and processes for the preparation thereof |
03/12/2009 | WO2009010139A3 Quinazolinamide derivatives |
03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
03/12/2009 | WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
03/12/2009 | US20090069402 Deuterium-enriched atrasentan |
03/12/2009 | US20090069383 Thrombin Receptor Antagonists |
03/12/2009 | US20090069335 Guanidine-containing compounds useful as muscarinic receptor antagonists |
03/12/2009 | US20090069316 Novel quinoline derivatives |
03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
03/12/2009 | US20090069252 C-glycoside derivatives and salts thereof |
03/12/2009 | US20090068718 Amino acid derivatives of indolinone based protein kinase inhibitors |
03/12/2009 | CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors |
03/12/2009 | CA2698341A1 Gamma secretase modulators |
03/12/2009 | CA2684037A1 Compounds with anti-cancer activity |
03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
03/11/2009 | EP2033637A1 Therapeutic or prophylactic agent for leukemia |
03/11/2009 | EP2032561A2 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses |
03/11/2009 | EP2032560A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
03/11/2009 | EP2032545A2 Compounds that modulate hsp90 activity and methods for identifying same |
03/11/2009 | EP2032542A2 Heterocyclic aspartyl protease inhibitors |
03/11/2009 | EP2032541A2 Novel viral replication inhibitor |
03/11/2009 | EP2032530A1 Pyrrolidine compounds as renin inhibitors |
03/11/2009 | EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
03/11/2009 | EP1358165B1 Imidazole derivatives |
03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
03/11/2009 | EP1319659B1 Triazinones and medicinal use thereof |
03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
03/11/2009 | EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk) |
03/11/2009 | CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
03/11/2009 | CN101384577A Novel coumarin derivative having antitumor activity |
03/11/2009 | CN101384559A Benzimidazole derivatives and their use for modulating the GABA-A receptor complex |
03/11/2009 | CN101384558A Gaba-b receptor modulators |
03/11/2009 | CN101384183A Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
03/11/2009 | CN101381361A Organic compound for recording layer and optical recording medium including the same |
03/11/2009 | CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same |
03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
03/11/2009 | CN100467443C 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
03/10/2009 | US7501525 Derivatives of benzimidazole and their use as medicaments |
03/10/2009 | US7501524 Melacocortin receptors; analgesics; antiinflammatory agents; eating disorders; psychological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
03/10/2009 | US7501450 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
03/10/2009 | US7501445 Imidazolidinone compounds |
03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
03/10/2009 | US7501429 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
03/10/2009 | US7501419 4-Squarylpiperazine derivatives as antiviral agents |
03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/10/2009 | US7501416 Quinoxaline compounds and methods of using them |
03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
03/10/2009 | CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
03/10/2009 | CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
03/10/2009 | CA2345069C 2-phenylpyran-4-one derivatives |
03/05/2009 | WO2009029735A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
03/05/2009 | WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
03/05/2009 | WO2009027264A1 Benzimidazole derivatives used as fxr agonists |
03/05/2009 | WO2009026658A1 Ppar agonists |
03/05/2009 | WO2009026657A1 Flavonoid ppar agonists |
03/05/2009 | WO2009010477A8 Piperidine-4-acetic acid derivatives and their use |
03/05/2009 | WO2009005677A3 Antiviral compounds |
03/05/2009 | WO2008147812A3 4' substituted compounds having 5-ht6 receptor affinity |
03/05/2009 | WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors |
03/05/2009 | WO2008070447A3 Anti-viral compounds |
03/05/2009 | WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors |
03/05/2009 | US20090062553 Process and Intermediates Useful in the Preparation of Statins, Particularly Atorvastatin |
03/05/2009 | US20090062533 5-hydroxy-7H-benzo[C]fluorene derivatives: 7,7-dimethyl-5-hydroxy-9-morpholino-7H-benzo[C]fluorene; intermediates for preparing indeno-fused naphthopyrans exhibiting reversible photochromism |
03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
03/05/2009 | US20090062358 Peroxisome proliferator activated receptor alpha agonists |
03/05/2009 | US20090062342 Amines |
03/05/2009 | US20090062317 Medicinal use of receptor ligands |
03/05/2009 | US20090062308 Methods of using sodium channel blockers |
03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
03/05/2009 | US20090062300 Deuterium-enriched prazosin |
03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
03/05/2009 | US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
03/05/2009 | US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
03/05/2009 | US20090062251 Novel Compounds 002 |
03/05/2009 | US20090060968 Inhibitors of phosphatases |
03/05/2009 | US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use |
03/05/2009 | US20090060874 Bicyclic pyrrolidine derivatives |
03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
03/05/2009 | CA2697382A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators |
03/05/2009 | CA2697167A1 Benzimidazole derivatives used as fxr agonists |
03/05/2009 | CA2695644A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
03/04/2009 | EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors |